An assessment of desflurane for use during cardiac electrophysiological study and radiofrequency ablation of supraventricular dysrhythmias in children

Paediatric Anaesthesia

Volumn 10, Issue 2, 2000, Pages 155-159

  Schaffer, Michael S ^a   Snyder, Andrew M ^a   Morrison, John E ^a,b  

^a CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Anaesthesia: cardiovascular; Anaesthetics, volatile: desflurane; Cardiology; Dysrhythmia: WPW, preexcitation, SVT; Radiofrequency ablation

Indexed keywords

DESFLURANE; FENTANYL; LORAZEPAM; ROCURONIUM; THIOPENTAL;

ADOLESCENT; ARTICLE; CATHETER ABLATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HEART ELECTROPHYSIOLOGY; HEART MUSCLE REFRACTORY PERIOD; HEART RATE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RADIOFREQUENCY;

ADMINISTRATION, ORAL; ANDROSTANOLS; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ATRIAL FUNCTION; BLOOD PRESSURE; CATHETER ABLATION; CHILD; CROSS-OVER STUDIES; ELECTROCARDIOGRAPHY; FENTANYL; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; ISOFLURANE; LORAZEPAM; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PREANESTHETIC MEDICATION; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; STATISTICS; TACHYCARDIA, SUPRAVENTRICULAR; THIOPENTAL;

EID: 0034021901     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2000.00465.x     Document Type: Article

References (26)

1. 1 Renwick J, Kerr C, McTaggart R et al. Cardiac electrophysiology and conduction pathway ablation. Can J Anaesth 1993; 40: 1053-1064.
2. 2 Randle DW, Hecker RB. Supraventricular tachycardia -classification, diagnosis, and treatment. Anesthesiol Rev 1994; 21: 185-197.
3. 3 Van Hare GF, Lesh MD, Scheinman M et al. Percutaneous radiofrequency catheter ablation for supraventricular arrhythmias in children. J Am Coll Cardiol 1991; 17: 1613-1620.
4. 4 Walsh EP, Saul JP. Transcatheter ablation for pediatric tachyarrhythmias using radiofrequency electrical energy. Pediatr Annals 1991; 20: 386-392.
5. 5 Dick MII, O'Connor BK, Serwer CA et al. Use of radiofrequency current to ablate accessory connections in children. Circulation 1991; 84: 2318-2324.
6. 6 Tinker JH. Desflurane: first new volatile anesthetic in almost 20 years. Anesth Analg 1992; 75: S1-S2.
7. 7 Eger EI II. Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC. Anesth Analg 1992; 75: S3-S9.
8. 8 Warltier DC, Pagel PS. Cardiovascular and respiratory actions of desflurane: is desflurane different from isoflurane? Anesth Analg 1992; 75: S17-S31.
9. 9 Taylor RH, Lerman J. Minimum alveolar concentration of desflurane and hemodynamic responses in neonates, infants, and children. Anesthesiology 1991; 75: 975-979.
10. 10 Morrison JE, Schaffer M. Laryngoscopy and arrhythmias in children. Can J Anaes 1995; 42: 748-749.
11. 11 Mannion D, Casey W, Doherty P. Desflurane in paediatric anaesthesia. Paediatric Anaesthesia 1994; 4: 301-306.
12. 12 Van der Starre PJ. Wolff-Parkinson-White syndrome during anesthesia. Anesthesiology 1978; 48: 369-372.
13. 13 Sadowski AR, Moyers JR. Anesthetic management of the Wolff-Parkinson-White Syndrome. Anesthesiology 1979; 51: 553-556.
14. 14 Sharpe MD, Dobkowski WB, Murkin JM et al. The electrophysiologic effects of volatile anesthetics and sufentanil on the normal atrioventricular conduction system and accessory pathways in Wolff-Parkinson-White syndrome. Anesthesiology 1994; 80: 63-70.
15. 15 Zimmerman AA, Ibrahim AE, Epstein MR et al. The effects of halothane and sevoflurane on cardiac electrophysiology in children undergoing radiofrequency catheter ablation. Anesthesiology 1997; 87: A1066.
16. 16 Sharpe MD, Dobkowski WB, Murkin JM et al. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White Syndrome during alfentanil/midazolam anesthesia. Anesthesiology 1995; 82: 888-895.
17. 17 Lavoie J, Walsh EP, Burrows FA et al. Effects of propofol or isoflurane anesthesia on cardiac conduction in children undergoing radiofrequency catheter ablation for tachydysrhythmias. Anesthesiology 1995; 82: 884-887.
18. 18 Scheffer GJ, Jonges R, Holley HS et al. Effects of halothane on the conduction system of the heart in humans. Anesth Analg 1989; 69: 721-726.
19. 19 Hantler CB, Wilton NC, Knight PR. Comparative effects of halothane, enflurane, and isoflurane on atrioventricular conductivity and subsidiary pacemaker function in dogs. Anesth Analg 1994; 79: 455-459.
20. 20 Sigurdsson GH, Lindahl SGE, Norden ND. Catecholamine and endocrine response in children during halothane and enflurane anaesthesia for adenoidectomy. Acta Anaesthesiol Scand 1984; 28: 47-51.
21. 21 Atlee JL. Halothane. Cause or cure for arrhythmias? (editorial). Anesthesiology 1987; 67: 617-618.
22. 22 Ganansia M-F, Francois TP, Ormezzano X et al. Atrioventricular Mobitz I block during propofol anesthesia for laparoscopic tubal ligation. Anesth Analg 1989; 69: 524-535.
23. 23 Colson P, Barlet H, Roquefeuill B. Mechanism of propofol bradycardia. Anesth Analg, 1988; 67: 906-907.
24. 24 Tanus dos Santos JE. Propofol suppresses premature atrial contractions during anesthesia. Pediatr Cardiol 1998; 19: 272.
25. 25 Hermann R, Vettermann J. Change of ectopic supraventricular tachycardia to sinus rhythm during administration of propofol. Anesth Analg 1992; 75: 1030-1032.
26. 26 Gomez-Arnau J, Marquez-Montes J, Avello F. Fentanyl and droperidol effects on the refractoriness of the accessory pathways in the Wolff-Parkinson-White syndrome. Anesthesiology 1983; 58: 307-313.